首页> 外文期刊>Nitric oxide: Biology and chemistry >Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers
【24h】

Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers

机译:摄入硝酸盐可改善健康志愿者的血管顺应性,但不会改变血流介导的扩张

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Ingestion of inorganic nitrate elevates blood and tissue levels of nitrite via bioconversion in the entero-salivary circulation. Nitrite is converted to NO in the circulation, and it is this phenomenon that is thought to underlie the beneficial effects of inorganic nitrate in humans. Our previous studies have demonstrated that oral ingestion of inorganic nitrate decreases blood pressure and inhibits the transient endothelial dysfunction caused by ischaemia-reperfusion injury in healthy volunteers. However, whether inorganic nitrate might improve endothelial function per se in the absence of a pathogenic stimulus and whether this might contribute to the blood pressure lowering effects is yet unknown. We conducted a randomised, double-blind, crossover study in 14 healthy volunteers to determine the effects of oral inorganic nitrate (8 mmol KNO _3) vs. placebo (8 mmol KCl) on endothelial function, measured by flow-mediated dilatation (FMD) of the brachial artery, prior to and 3 h following capsule ingestion. In addition, blood pressure (BP) was measured and aortic pulse wave velocity (aPWV) determined. Finally, blood, saliva and urine samples were collected for chemiluminescence analysis of [nitrite] and [nitrate] prior to and 3 h following interventions. Inorganic nitrate supplementation had no effect on endothelial function in healthy volunteers (6.9 ± 1.1% pre- to 7.1 ± 1.1% post-KNO _3). Despite this, there was a significant elevation of plasma [nitrite] (0.4 ± 0.1 μM pre- to 0.7 ± 0.2 μM post-KNO _3, p < 0.001). In addition these changes in [nitrite] were associated with a decrease in systolic BP (116.9 ± 3.8 mm Hg pre- vs. 112.1 ± 3.4 mm Hg post-KNO _3, p < 0.05) and aPWV (6.5 ± 0.1 m/s pre- to 6.2 ± 0.1 post-KNO _3, p < 0.01). In contrast KCl capsules had no effect on any of the parameters measured. These findings demonstrate that although inorganic nitrate ingestion does not alter endothelial function per se, it does appear to improve blood flow, in combination with a reduction in blood pressure. It is likely that these changes are due to the intra-vascular production of NO.
机译:通过肠唾液循环中的生物转化,摄入无机硝酸盐可提高血液和亚硝酸盐的组织水平。亚硝酸盐在循环中转化为NO,正是这种现象被认为是无机硝酸盐对人类有益作用的基础。我们以前的研究表明,口服硝酸盐可降低健康志愿者的血压,并抑制缺血再灌注损伤引起的短暂内皮功能障碍。然而,在没有病原性刺激的情况下,无机硝酸盐本身是否会改善内皮功能,以及是否可能有助于降低血压的作用尚不清楚。我们对14位健康志愿者进行了一项随机,双盲,交叉研究,以确定口服无机硝酸盐(8 mmol KNO _3)与安慰剂(8 mmol KCl)对内皮功能的影响,方法是通过流介导的扩张(FMD)进行测量胶囊摄入之前和之后的3小时另外,测量血压(BP)并确定主动脉脉搏波速度(aPWV)。最后,在干预前和干预后3 h收集血液,唾液和尿液样本进行[亚硝酸盐]和[硝酸盐]的化学发光分析。补充无机硝酸盐对健康志愿者的内皮功能没有影响(KNO _3后为6.9±1.1%至7.1±1.1%)。尽管如此,血浆[亚硝酸盐]仍显着升高(KNO _3前为0.4±0.1μM至KNO_3之后为0.7±0.2μM,p <0.001)。此外,[亚硝酸盐]的这些变化与收缩压降低(前KNO _3后为116.9±3.8 mm Hg vs. KNO _3后为112.1±3.4 mm Hg,p <0.05)和aPWV(前期6.5±0.1 m / s)有关-在KNO _3之后达到6.2±0.1,p <0.01)。相反,氯化钾胶囊对所测得的任何参数均无影响。这些发现表明,尽管无机硝酸盐的摄入本身并不会改变内皮功能,但它确实改善了血液流动,同时降低了血压。这些变化很可能是由于血管内NO的产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号